SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

Schlitt H. J.; Nashan B.; Schemmer P.; Pascher A.; Klein C. G.; Neumann U.; Kroeger I.; Wimmer P.; Braun F.

首页> 外文期刊>Transplant international : >SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

【24h】

SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

机译：早期使用everolimus的安全性和有效性与降低的肝血母动血症与De Novo肝脏移植受试者的标准躯杆蛋白组合：Hephaistos研究12个月数据

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplant international :》 |2019年第s3期|共1页
作者
Schlitt H. J.; Nashan B.; Schemmer P.; Pascher A.; Klein C. G.; Neumann U.; Kroeger I.; Wimmer P.; Braun F.;
展开▼
作者单位

Hephaistos Study Grp Nurnberg Germany;

Hephaistos Study Grp Nurnberg Germany;

Hephaistos Study Grp Nurnberg Germany;

Hephaistos Study Grp Nurnberg Germany;

Hephaistos Study Grp Nurnberg Germany;

Hephaistos Study Grp Nurnberg Germany;

Novartis Pharma GmbH Nurnberg Germany;

Novartis Pharma GmbH Nurnberg Germany;

Hephaistos Study Grp Nurnberg Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词

相似文献

外文文献
专利

1. SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA [J] . Schlitt H. J., Nashan B., Schemmer P., Transplant international : . 2019,第S3期

机译：早期使用everolimus的安全性和有效性与降低的肝血母动血症与De Novo肝脏移植受试者的标准躯杆蛋白组合：Hephaistos研究12个月数据
2. EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IMPROVES KIDNEY FUNCTION VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA [J] . Braun F., Nashan B., Pascher A., Transplant international : . 2019,第S3期

机译：everolimus与减少的Tacolimus相结合，改善了肾功能与标准的曲罗莫司在De Novo肝脏移植受者：Hephaistos研究12个月数据
3. EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY [J] . Saliba F., Duvoux C., Durand F., Transplant international : . 2015,第Suppla1期

机译：在从头移植肝受体中，依维莫司和减少的滑石质联合使用的有效性和安全性：来自随机H2304研究的36个月结果
4. Localized Tacrolimus Delivery for Transplant Rejection Prevention via TyroSphere-loaded Rapidly Soluble Films [C] . Joseph Molde, Antonio Merolli, Joseph A.M. Steele, Society for Biomaterials annual meeting and exposition . 2019

机译：他克莫司的局部递送，可通过载有TyroSphere的快速可溶薄膜预防移植排斥
5. An in vivo and in vitro comparative renal toxicity study of the immunosuppressant mTOR inhibitors everolimus and sirolimus in combination with the calcineurin inhibitors cyclosporine and tacrolimus [D] . Bohra, Rahul 2012

机译：免疫抑制剂mTOR抑制剂依维莫司和西罗莫司与钙调神经磷酸酶抑制剂环孢霉素和他克莫司联用的体内和体外比较肾毒性研究
6. Design and rationale of the ATHENA study – A 12-month multicentre prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial [O] . Claudia Sommerer, Barbara Suwelack, Duska Dragun, 2016

机译：ATHENA研究的设计和基本原理–一项为期12个月的多中心前瞻性研究评估了从头进行依维莫司治疗与环孢素或他克莫司减量相较于标准方案在肾移植患者中的治疗效果：随机对照研究方案试用
7. Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus inDe NovoRenal Transplant Recipients: 12-Month Data [O] . Y. Qazi, D. Shaffer, B. Kaplan, 2017

机译：everolimus加上低剂量标准司的功效和安全性与霉酚酸酯Mofetil加上标准剂量Tacrolimus Inde NovoreNal移植受者：12个月的数据

SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

著录项

相似文献

相关主题

期刊订阅